Loading...

ALXO ALX ONCOLOGY HOLDINGS INC Management Changes 8-K Filing

LX N

LX

ALX ONCOLOGY HOLDINGS INC

(ALXO)

2024 8-K

Show Summary

Show Summary

Financial Statements

Notice of Delisting

Financial Results

Workforce Reduction

Management Changes

Equity Incentive Plan

Management Changes

Management Change

Earnings Reports

Appointment of Director and...

Annual Meeting of Stockholders

Earnings Reports

Resignation of Directors

Financial Results Announcement

Loan Agreement Amendment

Financial Results Announcement

Underwriting Agreement for ...

Earnings Reports

Study Protocol and Interim ...

Financial Results Announcement

Amended and Restated Bylaws

Earnings Reports

FDIC Receivership

Financial Results Announcement

External Links:

Dr. Sophia Randolph, Chief Medical Officer of ALX Oncology, resigned effective October 11, 2024, and will receive a separation payment of $503,880 along with health coverage for 18 months and accelerated vesting of stock options.

AI Assistant

ALX ONCOLOGY HOLDINGS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.